Biontech Se ADR
(BNTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,225,081 | -360,235 | 1,283,716 | 569,124 | 322,213 |
| Depreciation Amortization | 94,983 | 41,582 | 198,494 | 113,847 | 69,022 |
| Accounts receivable | 2,259,121 | 540,896 | 5,816,280 | 7,236,336 | 6,561,373 |
| Accounts payable and accrued liabilities | 509,158 | -312,682 | 128,686 | -319,881 | -293,209 |
| Other Working Capital | 2,787,232 | 241,568 | 6,033,606 | 6,942,468 | 6,258,024 |
| Other Operating Activity | -3,014,782 | -495,622 | -7,647,315 | -9,621,782 | -8,872,803 |
| Operating Cash Flow | $1,410,631 | $-344,493 | $5,813,466 | $4,920,112 | $4,044,621 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | -3,708,396 | N/A |
| PPE Investments | -158,197 | -63,514 | -270,683 | -181,110 | -122,561 |
| Net Acquisitions | N/A | N/A | -364,627 | -366,682 | N/A |
| Purchase Of Investment | -7,908,000 | -5,314,610 | -7,715,067 | N/A | -2,903,844 |
| Sale Of Investment | 5,465,806 | 2,961,355 | 1,316,401 | N/A | N/A |
| Purchase Sale Intangibles | -141,182 | -85,119 | -492,879 | -379,743 | -274,454 |
| Other Investing Activity | -141,181 | -85,119 | -492,879 | -379,743 | -274,454 |
| Investing Cash Flow | $-2,741,572 | $-2,501,887 | $-7,526,855 | $-4,635,931 | $-3,300,859 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 325 | 109 | N/A |
| Debt Repayment | -2,477 | N/A | -108 | -109 | N/A |
| Common Stock Repurchased | N/A | N/A | -799,279 | -802,913 | -475,414 |
| Other Financing Activity | -30,584 | -8,469 | -43,617 | -30,475 | -20,391 |
| Financing Cash Flow | $-33,061 | $-8,469 | $-842,679 | $-833,388 | $-495,805 |
| Exchange Rate Effect | 3,769 | 7,383 | -15,693 | 136,377 | 69,895 |
| Beginning Cash Position | 12,560,640 | 12,663,280 | 15,017,020 | 15,101,660 | 15,129,410 |
| End Cash Position | 11,174,670 | 9,745,895 | 12,623,620 | 14,688,830 | 15,447,260 |
| Net Cash Flow | $-1,385,970 | $-2,917,385 | $-2,393,398 | $-412,830 | $317,852 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,410,631 | -344,493 | 5,813,466 | 4,920,112 | 4,044,621 |
| Capital Expenditure | -158,412 | -63,514 | -269,926 | -180,239 | -122,561 |
| Free Cash Flow | 1,252,219 | -408,006 | 5,543,540 | 4,739,873 | 3,922,060 |